MOOG INC. 10-Q Summary: Quarter Ended July 1, 2006
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for MOOG INC., a global designer and manufacturer of precision motion and fluid controls for aerospace, defense, industrial, and medical markets. The report covers the three and nine-month periods ended July 1, 2006. The fiscal year 2006 is a 53-week year, while 2005 was a 52-week year; the nine-month period in 2006 includes 40 weeks compared to 39 weeks in 2005.
Key Financial Metrics
| Metric | Three Months Ended July 1, 2006 | Nine Months Ended July 1, 2006 |
|---|---|---|
| Net Sales | $333.5 million | $965.7 million |
| Gross Profit | $108.8 million (32.6% margin) | $313.2 million (32.4% margin) |
| Net Earnings | $21.2 million | $59.5 million |
| Diluted EPS | $0.50 | $1.46 |
| Operating Cash Flow (9mo) | $30.2 million | |
| Total Debt (Long-term + Current) | ~$399.2 million | |
| Cash and Equivalents | $47.1 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 25% year-over-year for both the quarter and the nine-month period, driven by organic growth and acquisitions.
- Profitability: Net earnings increased 28% for the quarter and 26% for the nine-month period. Operating margins improved to 12.3% (quarter) and 12.6% (nine months) compared to 11.8% and 11.7% in the prior year.
- Acquisitions: Significant activity included the acquisition of Curlin Medical (creating a new Medical Devices segment), Flo-Tork, FCS Control Systems, and the Power and Data Technologies Group of Kaydon Corporation.
- Accounting Changes: The company adopted SFAS No. 123(R) in Q1 2006, resulting in the recognition of stock-based compensation expense ($3.0 million for the nine months), which reduced EPS by approximately $0.06 compared to prior year pro forma figures.
- Interest Expense: Increased significantly due to higher debt levels associated with acquisitions and the issuance of senior subordinated notes in 2005.
Guidance, Outlook, and Risks
2006 Outlook: Management expects full-year net sales to increase 23% to $1.29 billion. Operating margins are projected to rise to 12.6%. Diluted EPS is expected to increase 20% to $1.96, despite the impact of stock compensation expense.
2007 Outlook: Sales are forecast to grow 10-12% to between $1.421 billion and $1.441 billion. Operating margins are expected to be 12.7%. Net earnings are projected between $94 million and $98 million, with diluted EPS ranging from $2.21 to $2.29.
Risks and Contingencies:
- Customer Concentration: Significant dependence on major customers like Boeing and Lockheed Martin.
- Government Contracts: Risk of termination or funding delays for military and government programs.
- Acquisition Integration: Risks associated with integrating new businesses and potential unknown liabilities.
- Foreign Currency: A stronger U.S. dollar in the first nine months of 2006 reduced reported sales by approximately $13 million.
- Debt Covenants: The company maintains significant indebtedness and must comply with leverage and coverage ratios under its credit facilities.
Investor Verification Checklist
- Acquisition Synergies: Verify the integration progress and financial performance of Curlin Medical, Flo-Tork, and Kaydon Power & Data Technologies against management's projections.
- Boeing 787 Program: Monitor R&D expenses and revenue recognition related to the Boeing 787 Dreamliner, which is driving increased costs in the Aircraft Controls segment.
- Debt Servicing: Review the impact of increased interest rates and debt levels on future cash flows and covenant compliance.
- Stock Compensation Impact: Assess the ongoing effect of SFAS 123(R) on future earnings per share as stock option grants vest.
- Foreign Exchange Exposure: Evaluate the sensitivity of the Industrial Controls segment to fluctuations in the Euro and Yen against the U.S. dollar.